Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration. (scientific article published in March 2017)

An investigation of modifying effects of metallothionein single-nucleotide polymorphisms on the association between mercury exposure and biomarker levels

Q23924036

Complement factor H polymorphism in age-related macular degeneration

Q24553334

Human metallothionein genes are clustered on chromosome 16

Q24607740

PLINK: a tool set for whole-genome association and population-based linkage analyses

Q24677407

The structure of haplotype blocks in the human genome

Q27860500

Haploview: analysis and visualization of LD and haplotype maps

Q27860955

High concentration of zinc in sub-retinal pigment epithelial deposits

Q28289340

Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc

Q28397320

Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes

Q28943546

Statistical Methods in Medical Research

Q29013788

Seven new loci associated with age-related macular degeneration

Q29416998

Zinc in the retina

Q32150499

Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Q34378842

Age-related macular degeneration: genetic and environmental factors of disease

Q34407622

Risk factors for age-related macular degeneration: an update

Q34638046

Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye

Q35062847

Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance

Q35083535

The epidemiology of age-related macular degeneration

Q35688105

Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation

Q35761464

p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy

Q35784131

Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics

Q36084168

The stoichiometric transition from Zn6Cu1-metallothionein to Zn7-metallothionein underlies the up-regulation of metallothionein (MT) expression: quantitative analysis of MT-metal load in eye cells

Q36217420

Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics

Q36405448

Zinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration

Q36967403

Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer

Q37535008

The molecular genetic basis of age-related macular degeneration: an overview

Q37678798

Cytosolic zinc buffering and muffling: Their role in intracellular zinc homeostasis

Q37808632

Metallothionein polymorphisms in pathological processes

Q38143589

Metallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle.

Q38178092

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Q38238059

Potential effect on cellular response to cadmium of a single-nucleotide A --> G polymorphism in the promoter of the human gene for metallothionein IIA.

Q38310397

The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population

Q38352615

Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons

Q39962333

CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration

Q41604701

Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population

Q43123415

Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc.

Q44414904

Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.

Q44686582

Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma.

Q46095668

Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.

Q46864234

Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population.

Q51787583

Association between metallothionein genes polymorphisms and sporadic amyotrophic lateral sclerosis in a Japanese population.

Q51945485

Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population.

Q53083502

The potential effect of metallothionein 2A -5A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels.

Q54358919

Overexpression of metallothionein confers resistance to anticancer drugs.

Q54376480

Metallothionein-1 genotypes in the risk of oral squamous cell carcinoma.

Q54398982

Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications.

Q54541622

P433

issue

P304

page(s)

451-458

P577

publication date

2017-03-01

P1433

published in

Ophthalmic Genetics

Q15759083

P1476

title

Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.

P478

volume